AUS
NZ
UK
CA
USA
IND
Healthcare
Discover How BSF Enterprise Is Expanding Beyond Luxury Innovation
June 16, 2026 01:04 PM BST| By Vivek SinghBSF Enterprise highlights the commercial potential of its advanced tissue engineering platform as industry interest grows across sustainable materials, automotive innovation, footwear applications, and regenerative healthcare solutions.
Poolbeg Pharma Expands Its European Footprint with Patent Milestone
June 16, 2026 11:59 AM BST| By Vivek SinghPoolbeg Pharma strengthens its European intellectual property portfolio with a new patent grant as clinical development advances, supporting future commercial opportunities in immune-related complications linked to cancer treatments.
Why Is Every Eye On GSK's Dealmaking Spree This Summer?
June 16, 2026 06:45 AM BST| By Vivek SinghGSK (LSE:GSK) has continued an active stretch of acquisitions aimed at strengthening its cancer pipeline, drawing fresh attention to how UK pharmaceutical companies are positioning for the years ahead.
Sponsored
Could International Expansion Unlock Significant Value for Applied Nutrition?
June 16, 2026 03:43 PM BST| By Ishan MudgalThe business combines product innovation, brand development, retail distribution, and international expansion strategies to strengthen its market position. As consumer demand for premium nutritional products continues to rise, Applied Nutrition aims to capitalize on both domestic and international opportunities.
Is AstraZeneca Still The Heavyweight Everyone Watches?
June 16, 2026 06:45 AM BST| By Vivek SinghAstraZeneca (LSE:AZN) continues to function as a benchmark for the UK pharmaceutical sector, its scale and broad pipeline keeping it central to how investors read healthcare more widely.
The Healthcare Names That Quietly Power Hospitals Worldwide
June 16, 2026 06:45 AM BST| By Vivek SinghBeyond the largest drugmakers, names such as Smith & Nephew (LSE:SN.), Hikma Pharmaceuticals (LSE:HIK) and ConvaTec Group (LSE:CTEC) illustrate the breadth of the UK healthcare sector.
4basebio Expands Scientific Expertise for the Future of Genetic Medicine
June 15, 2026 02:15 PM BST| By Vivek Singh4basebio (LSE:4BB) expands its scientific capabilities with a strategic advisory appointment, supporting innovation in synthetic DNA technologies for mRNA therapeutics, gene editing, and advanced genetic medicine development.
Sponsored
Is Dialight PLC Well Positioned for Long-Term Industrial Growth?
June 16, 2026 02:23 PM BST| By Ishan MudgalDialight PLC is a specialist provider of industrial LED lighting solutions designed for hazardous, heavy industrial, and infrastructure environments. The company serves a broad range of industries, including oil and gas, mining, power generation, manufacturing, transportation, and other mission-critical sectors where reliability, durability, and …
Haleon (LSE:HLN) Advances Capital Strategy with Share Cancellation Initiative
June 15, 2026 12:44 PM BST| By Vivek SinghHaleon (LSE:HLN) continues its share cancellation initiative as part of a broader capital management strategy, reinforcing transparency, governance standards, and long-term shareholder value creation.
FDA Approval Opens New Chapter for AstraZeneca’s Oncology Growth
June 14, 2026 06:24 PM BST| By Vivek SinghFDA approval of TRUQAP strengthens AstraZeneca’s precision oncology portfolio, highlighting advances in targeted prostate cancer treatment and the growing importance of biomarker-driven healthcare solutions.
AI Healthcare Revolution: Three UK Stocks Worth Watching
June 12, 2026 01:57 PM BST| By Vivek SinghDiscover how artificial intelligence is transforming healthcare innovation and explore the role of IXICO, AstraZeneca, and EMV Capital in advancing diagnostics, drug development, and healthcare technology.
Sponsored
Can Resource Development Drive Long-Term Growth for Kendrick Resources PLC?
June 16, 2026 02:22 PM BST| By Ishan MudgalAs global economies accelerate efforts toward electrification and decarbonization, the importance of critical minerals continues to grow. Exploration companies with exposure to these commodities are attracting investor interest because successful discoveries could play a vital role in future supply chains. Kendrick Resources seeks to …
How Cizzle Biotechnology’s US Patent Could Shape Lung Cancer Diagnostics
June 12, 2026 01:20 PM BST| By Vivek SinghCizzle Biotechnology secures a US patent for its lung cancer biomarker technology, supporting commercial expansion, strengthening intellectual property protection, and advancing early detection solutions in global healthcare markets.
BSF Enterprise Strengthens Bio-Leather Momentum Across Global Industries
June 12, 2026 09:15 AM BST| By Vivek SinghBSF Enterprise explores new opportunities for its bio-leather technology as luxury, automotive, and sportswear sectors continue evaluating advanced sustainable material solutions.
Can Healthcare Shares Really Shelter Portfolios From Geopolitical Storms?
June 11, 2026 11:38 AM BST| By Vivek SinghWith London indices near multi-week lows on Middle East tension, investors are leaning on defensive sectors. We examine whether UK healthcare shares are living up to their safe-haven billing.
Sponsored
What Is Driving Investor Selling Pressure in Newbury Racecourse Despite Multiple Revenue Streams?
June 16, 2026 10:32 AM BST| By Ankur SharmaNewbury Racecourse PLC came under pressure after declining 6.98%, attracting investor attention across the leisure, hospitality and property investment sectors. Despite operating one of the UK's best-known racecourses and event venues, the company experienced notable selling pressure as investors reassessed valuation, consumer spending trends …
Is UK Pharma Quietly Building Its Next Generation of Blockbusters?
June 11, 2026 11:35 AM BST| By Vivek SinghFrom oncology dealmaking to obesity research and regulatory milestones, Britain's listed drugmakers are locked in a race to refill their pipelines — a contest now shaping the UK healthcare sector's narrative.
AstraZeneca and GSK in Focus as Regulatory and Deal News Stirs UK Healthcare
June 11, 2026 11:29 AM BST| By Vivek SinghUK healthcare shares are in the spotlight as AstraZeneca faces an extended regulatory timeline for a key oncology filing and GSK digests reaction to a major acquisition, all against a risk-off London market.
Why Healthcare Stocks Are Back In The London Conversation
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
Sponsored
Why Did LSE:TBLD - tinyBuild Inc. Surge and Could the Video Game Publisher Be Entering a Recovery Phase?
June 16, 2026 10:22 AM BST| By Ankur SharmaLSE:TBLD - tinyBuild Inc. has emerged as one of the strongest-performing technology and gaming-related shares on the UK market after delivering a substantial upward move that reignited investor interest. Across Google Finance, Yahoo Finance, gaming investment forums, technology stock communities, and FTSE AIM investor …
Healthcare Stocks Face A New Test From London Sentiment
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
Healthcare Stocks And The Sector Shift Shaping Attention
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
What's Behind the Flurry of Regulatory Wins for UK Pharma Giants?
June 10, 2026 12:09 PM BST| By Vivek SinghA wave of regulatory milestones, from AstraZeneca's oncology approvals to GSK's respiratory green lights in Asia, has kept UK healthcare companies in the headlines as investors digest a busy news cycle.
Sponsored
FTSE 100, FTSE 250 & AIM Market Wrap: UK Stocks Navigate Geopolitical Relief Rally as Investors Eye New Opportunities – 15 June 2026
June 16, 2026 04:42 AM BST| By Ankur Sharma
From Lab Bench to Blue Chips: The Hidden Engine of London's Healthcare Scene
June 10, 2026 12:05 PM BST| By Vivek SinghThe UK healthcare sector is evolving beyond its defensive reputation, with regulatory reform, oncology breakthroughs and life sciences innovation reshaping how London-listed pharma, medtech and consumer health companies are perceived by investors.
Why Are Healthcare Shares Stealing the Spotlight as the FTSE Flirts With Records?
June 10, 2026 12:00 PM BST| By Vivek SinghHealthcare shares drew attention as London's blue-chip index hovered near record territory, with pharmaceutical heavyweights, medical device makers and consumer health names all featuring among the session's most-watched movers.
